apollomicsinc.com - Bathi operasional EBITDA APLM
Apollomics, Inc. (APLM) is optimizing expenses by outsourcing molecule development to external CRO contractors. Operating accruals before depreciation on GURU.Markets illustrate current trends, where 0.00 reflects the metric's baseline. The company is scaling anti-tumor therapies in the US and China, which mitigates regulatory risks. Additionally, the business is focusing on therapies for resistant forms of cancer through partnerships with leading clinics.
Ringkesan rincian data analitis Apollomics (APLM)
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Apollomics, Inc.|APLM - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Apollomics Inc.|APLM - Utang perusahaan|Utang-utang marang nilai buku Apollomics|APLM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Apollomics|Likuiditas cepet apollomicsinc.com
- statistik bathi lan rasio pasar:
APLM - Bathi resik perusahaan|Bathi resik sing dikarepake Apollomics, Inc.|APLM - Rasio rega marang bathi|Prakiraan rega marang bathi Apollomics Inc.|APLM - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Apollomics|APLM - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Apollomics|APLM - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan apollomicsinc.com|APLM - Wutah bathi resik saben saham ing taun iki|Dinamika bathi saben saham sing diarepake ing taun ngarep Apollomics, Inc.
Analisis kabeh metrik perusahaan:Apollomics, Inc.
Fundamental asset screening requires a precise analysis of cash flow from operating activities before deducting financial expenses and depreciation. By analyzing the EBITDA metric, an investor assesses the real ability of Apollomics, Inc. (APLM) to act as a cash generator, which is critical for covering the development costs of oncology drugs in the US and China amid the high binary risks of the clinical pipeline.
Pesaing Apollomics, Inc. (APLM)
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional EBITDA PSNL|Bathi operasional EBITDA erasca.com (ERAS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Delcath Systems DCTH|YMAB (Y-mAbs Therapeutics Inc) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Candel Therapeutics|Accuray Incorporated (ARAY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLS (SELLAS Life Sciences Group) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Actuate Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CTOR|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TuHURA Biosciences, Inc. (HURA)|TARA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fate Therapeutics, Inc. FATE|WHWK - Bathi operasional sadurunge ngurangi amortisasi|TScan - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Champions Oncology CSBR|XBIT: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi CEL-SCI|Bathi sadurunge mbayar bunga, pajak, lan amortisasi OS Therapies Incorporated|radiopharmtheranostics.com (RADX) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi ARTV (Artiva Biotherapeutics, Inc.)|ANL (adlainortye.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA VERU (Veru Pharma)|Pendapatan operasional sadurunge ngurangi amortisasi Tempest Therapeutics Corp (TPST)|XLO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RENB (Renovaro Inc.) - Bathi operasional sadurunge amortisasi|MURA: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Kairos Pharma|Bathi operasional sadurunge ngurangi amortisasi OKUR|CytoMed (GDTC) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA CRIS|Bathi operasional EBITDA tharimmune.com (THAR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Advanced Biomed ADVB|GNPX (Genprex Inc.) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|CLDI - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SBFM: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi salariuspharma.com|PPBT (Purple Biotech Ltd.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi AON (AONC)|Bathi operasional EBITDA BGNE|Bathi operasional EBITDA Checkpoint Therapeutics Inc (CKPT)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD: Bathi operasional sadurunge amortisasi|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi MorphoSys Corporation (MOR)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NAYA Biosciences|AAPGV: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi
